|
1
|
Smyth MJ, Hayakawa Y, Takeda K and Yagita
H: New aspects of natural-killer-cell surveillance and therapy of
cancer. Nat Rev Cancer. 2:850–861. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Levy EM, Roberti MP and Mordoh J: Natural
killer cells in human cancer: From biological functions to clinical
applications. J Biomed Biotechnol. 2011:6761982011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Coca S, Perez-Piqueras J, Martinez D,
Colmenarejo A, Saez MA, Vallejo C, Martos JA and Moreno M: The
prognostic significance of intratumoral natural killer cells in
patients with colorectal carcinoma. Cancer. 79:2320–2328. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ishigami S, Natsugoe S, Tokuda K, Nakajo
A, Che X, Iwashige H, Aridome K, Hokita S and Aikou T: Prognostic
value of intratumoral natural killer cells in gastric carcinoma.
Cancer. 88:577–583. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cheng M, Chen Y, Xiao W, Sun R and Tian Z:
NK cell-based immunotherapy for malignant diseases. Cell Mol
Immunol. 10:230–252. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Albertsson PA, Basse PH, Hokland M,
Goldfarb RH, Nagelkerke JF, Nannmark U and Kuppen PJ: NK cells and
the tumour microenvironment: Implications for NK-cellfunction and
anti-tumour activity. Trends Immunol. 24:603–609. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Balch CM, Tilden AB, Dougherty PA and
Cloud GA: Depressed levels of granular lymphocytes with natural
killer (NK) cell function in 247 cancer patients. Ann Surg.
198:192–199. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Levy S, Herberman R, Lippman M and
d'Angelo T: Correlation of stress factors with sustained depression
of natural killer cell activity and predicted prognosis in patients
with breast cancer. J Clin Oncol. 5:348–353. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schantz SP, Shillitoe EJ, Brown B and
Campbell B: Natural killer cell activity and head and neck cancer:
A clinical assessment. J Natl Cancer Inst. 77:869–875.
1986.PubMed/NCBI
|
|
10
|
Brunner KT, Mauel J, Cerottini JC and
Chapuis B: Quantitative assay of the lytic action of immune
lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro;
inhibition by isoantibody and by drugs. Immunology. 14:181–196.
1968.PubMed/NCBI
|
|
11
|
Pross HF, Baines MG, Rubin P, Shragge P
and Patterson MS: Spontaneous human lymphocyte-mediated
cytotoxicity against tumor target cells. IX. The quantitation of
natural killer cell activity. J Clin Immunol. 1:51–63. 1981.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim JC, Choi J, Lee SJ, Lee YA, Jeon YM,
Kang YW and Lee JK: Evaluation of cytolytic activity and phenotypic
changes of circulating blood immune cells in patients with
colorectal cancer by a simple preparation of peripheral blood
mononuclear cells. J Korean Surg Soc. 85:230–235. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
White D, Jones DB, Cooke T and Kirkham N:
Natural killer (NK) activity in peripheral blood lymphocytes of
patients with benign and malignant breast disease. Br J Cancer.
46:611–616. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hartung T and Daston G: Are in vitro tests
suitable for regulatory use? Toxicol Sci. 111:233–237. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Smith C, Jalbert E, de Almeida V, Canniff
J, Lenz LL, Mussi-Pinhata MM, Cohen RA, Yu Q, Amaral FR, Pinto J,
et al: Altered natural killer cell function in HIV-exposed
uninfected infants. Front Immunol. 8:4702017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mhatre S, Madkaikar M, Ghosh K, Desai M,
Pujari V and Gupta M: Rapid flow cytometry based cytotoxicity assay
for evaluation of NK cell function. Indian J Exp Biol. 52:983–988.
2014.PubMed/NCBI
|
|
17
|
Cho D, Shook DR, Shimasaki N, Chang YH,
Fujisaki H and Campana D: Cytotoxicity of activated natural killer
cells against pediatric solid tumors. Clin Cancer Res.
16:3901–3909. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Grimm EA, Mazumder A, Zhang HZ and
Rosenberg SA: Lymphokine-activated killer cell phenomenon. Lysis of
natural killer-resistant fresh solid tumor cells by interleukin
2-activated autologous human peripheral blood lymphocytes. J Exp
Med. 155:1823–1841. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tartter PI, Steinberg B, Barron DM and
Martinelli G: The prognostic significance of natural killer
cytotoxicity in patients with colorectal cancer. Arch Surg.
122:1264–1268. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin CC, Kuo YC, Huang WC and Lin CY:
Natural killer cell activity in lung cancer patients. Chest.
92:1022–1024. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hanna N and Schneider M: Enhancement of
tumor metastasis and suppression of natural killer cell activity by
beta-estradiol treatment. J Immunol. 130:974–980. 1983.PubMed/NCBI
|
|
22
|
Espi A, Arenas J, Garcia-Granero E, Marti
E and Lledó S: Relationship of curative surgery on natural killer
cell activity in colorectal cancer. Dis Colon Rectum. 39:429–434.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Beano A, Signorino E, Evangelista A, Brusa
D, Mistrangelo M, Polimeni MA, Spadi R, Donadio M, Ciuffreda L and
Matera L: Correlation between NK function and response to
trastuzumab in metastatic breast cancer patients. J Transl Med.
6:252008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pollock RE, Lotzová E and Stanford SD:
Mechanism of surgical stress impairment of human perioperative
natural killer cell cytotoxicity. Arch Surg. 126:338–342. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lennard TW, Shenton BK, Borzotta A,
Donnelly PK, White M, Gerrie LM, Proud G and Taylor RM: The
influence of surgical operations on components of the human immune
system. Br J Surg. 72:771–776. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pollock RE, Lotzová E and Stanford SD:
Surgical stress impairs natural killer cell programming of tumor
for lysis in patients with sarcomas and other solid tumors. Cancer.
70:2192–2202. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Greenfeld K, Avraham R, Benish M, Goldfarb
Y, Rosenne E, Shapira Y, Rudich T and Ben-Eliyahu S: Immune
suppression while awaiting surgery and following it: Dissociations
between plasma cytokine levels, their induced production, and NK
cell cytotoxicity. Brain Behav Immun. 21:503–513. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bryant J, Day R, Whiteside TL and
Herberman RB: Calculation of lytic units for the expression of
cell-mediated cytotoxicity. J Immunol Methods. 146:91–103. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pollock RE, Zimmerman SO, Fuchshuber P and
Lotzová E: Lytic units reconsidered: Pitfalls in calculation and
usage. J Clin Lab Anal. 4:274–282. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bloom ET and Korn EL: Quantification of
natural cytotoxicity by human lymphocyte subpopulations isolated by
density: Heterogeneity of the effector cells. J Immunol Methods.
58:323–335. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Montelli TC, Peraçoli MT, Gabarra RC,
Soares AM and Kurokawa CS: Familial cancer: Depressed NK-cell
cytotoxicity in healthy and cancer affected members. Arq
Neuropsiquiatr. 59:6–10. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim GS, Youn JK, Kim JD and Kim NH:
Natural killer cell activity in rheumatoid arthritis measured by a
single cell cytotoxicity assay. Yonsei Med J. 29:160–165. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fernandez NC, Lozier A, Flament C,
Ricciardi-Castagnoli P, Bellet D, Suter M, Perricaudet M, Tursz T,
Maraskovsky E and Zitvogel L: Dendritic cells directly trigger NK
cell functions: Cross-talk relevant in innate anti-tumor immune
responses in vivo. Nat Med. 5:405–411. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zingoni A, Sornasse T, Cocks BG, Tanaka Y,
Santoni A and Lanier LL: Cross-talk between activated human NK
cells and CD4+ T cells via OX40-OX40 ligand interactions. J
Immunol. 173:3716–3724. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Terme M, Chaput N, Combadiere B, Ma A,
Ohteki T and Zitvogel L: Regulatory T cells control dendritic
cell/NK cell cross-talk in lymph nodes at the steady state by
inhibiting CD4+ self-reactive T cells. J Immunol. 180:4679–4686.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ogawa K, Hirai M, Katsube T, Murayama M,
Hamaguchi K, Shimakawa T, Naritake Y, Hosokawa T and Kajiwara T:
Suppression of cellular immunity by surgical stress. Surgery.
127:329–336. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Na YM, Kim MY, Kim YK, Ha YR and Yoon DS:
Exercise therapy effect on natural killer cell cytotoxic activity
in stomach cancer patients after curative surgery. Arch Phys Med
Rehabil. 81:777–779. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Choi J, Lee SJ, Lee YA, Maeng HG, Lee JK
and Kang YW: Reference values for peripheral blood lymphocyte
subsets in a healthy korean population. Immune Netw. 14:289–295.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Saito H, Osaki T and Ikeguchi M: Decreased
NKG2D expression on NK cells correlates with impaired NK cell
function in patients with gastric cancer. Gastric Cancer. 15:27–33.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lee JC, Lee KM, Kim DW and Heo DS:
Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies
impaired NK cytotoxicity in cancer patients. J Immunol.
172:7335–7340. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hilpert J, Grosse-Hovest L, Grünebach F,
Buechele C, Nuebling T, Raum T, Steinle A and Salih HR:
Comprehensive analysis of NKG2D ligand expression and release in
leukemia: Implications for NKG2D-mediated NK cell responses. J
Immunol. 189:1360–1371. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Spear P, Wu MR, Sentman ML and Sentman CL:
NKG2D ligands as therapeutic targets. Cancer Immun.
13:82013.PubMed/NCBI
|
|
43
|
Bellone G, Aste-Amezaga M, Trinchieri G
and Rodeck U: Regulation of NK cell functions by TGF-beta 1. J
Immunol. 155:1066–1073. 1995.PubMed/NCBI
|
|
44
|
Sun C, Fu B, Gao Y, Liao X, Sun R, Tian Z
and Wei H: TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP
expression on human NK cells contributes to HBV persistence. PLoS
Pathog. 8:e10025942012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Krasagakis K, Thölke D, Farthmann B,
Eberle J, Mansmann U and Orfanos CE: Elevated plasma levels of
transforming growth factor (TGF)-beta1 and TGF-beta2 in patients
with disseminated malignant melanoma. Br J Cancer. 77:1492–1494.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ghiringhelli F, Ménard C, Terme M, Flament
C, Taieb J, Chaput N, Puig PE, Novault S, Escudier B, Vivier E, et
al: CD4+CD25+ regulatory T cells inhibit natural killer cell
functions in a transforming growth factor-beta-dependent manner. J
Exp Med. 202:1075–1085. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lima M, Teixeira MA, Queirós ML, Leite M,
Santos AH, Justiça B and Orfão A: Immunophenotypic characterization
of normal blood CD56+lo versus CD56+hi NK-cell subsets and its
impact on the understanding of their tissue distribution and
functional properties. Blood Cells Mol Dis. 27:731–743. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bryceson YT, Fauriat C, Nunes JM, Wood SM,
Björkström NK, Long EO and Ljunggren HG: Functional analysis of
human NK cells by flow cytometry. Methods Mol Biol. 612:335–352.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kane KL, Ashton FA, Schmitz JL and Folds
JD: Determination of natural killer cell function by flow
cytometry. Clin Diagn Lab Immunol. 3:295–300. 1996.PubMed/NCBI
|
